What Is Sermorelin? GHRH (1-29) Amide — Structure, Receptor Mechanism and Research Use

Sermorelin is GHRH (1–29) amide: a synthetic peptide reproducing the first 29 residues of the 44-residue human growth hormone-releasing hormone, finished with an amide at the C-terminus. Endocrinology established long ago that nearly all of the hormone's receptor-binding information sits in that opening stretch — and the truncation is the point of the molecule. Since residues 30–44 contribute nothing measurable to receptor activation, a 29-residue peptide gives you a cheaper, easier-to-make and chemically more tractable GHRH receptor probe than the intact hormone.

What follows covers where the sequence comes from, what it does at the pituitary, what has been published, and how laboratories specify and handle the material. Sermorelin is supplied as a freeze-dried powder.

Discovery and structure

Human GHRH was first obtained in 1982, not from hypothalamus but from pancreatic tumours in patients with acromegaly — an odd route, made possible because those tumours turned out to churn out the hypothalamic hormone in amounts no hypothalamus could provide. The peptide they isolated ran to 44 residues. The structure–activity studies that followed settled two matters: potency survives intact in the first 29 residues, and the N-terminus is untouchable, since deleting even residue destroys all activity.

What sermorelin is, then, is that 29-residue piece with an amide in place of the terminal carboxylate. Amidation makes it more than a simple truncation: removing that negative charge sharpens receptor binding, and it is something a certificate should demonstrate. There is exactly one methionine in the sequence, at position 27. Methionine is the residue that oxidises most readily, and it is the reason methionine oxidation features so persistently in stability discussions for this analogue family.

Structurally, sermorelin belongs to the secretin-glucagon superfamily, alongside secretin, glucagon, PACAP and VIP. All of these activate class B G protein-coupled receptors by the same two-step mechanism: the C-terminal part of the peptide anchors in the receptor's sizeable extracellular domain, after which the N-terminal residues slot into the transmembrane bundle and set signalling in motion. That explains why trimming residues from the C-terminus costs much less activity than trimming them from the N-terminus.

Mechanism of action

Sermorelin binds receptors for GHRH on the somatotroph cells of the anterior pituitary. Gs coupling drives cAMP upward, protein kinase A is activated, transcription of the growth hormone gene rises and stored hormone is secreted. The literature additionally associates prolonged exposure with somatotroph proliferation.

The appeal of this receptor as a research target lies in the fact that the secretion it drives remains physiologically regulated. Somatostatin tone still opposes release, and IGF-1 feedback continues to operate, so an agonist amplifies a rhythm that is already controlled rather than replacing it — quite unlike administering recombinant growth hormone, which bypasses the axis altogether. In animal work this shows up as preserved pulsatility, which is precisely why sermorelin appears in studies of hypothalamic-pituitary regulation.

Sermorelin also disappears fast. DPP-4 cleaves it just after the alanine at position 2, and the plasma half-life reported is a few minutes at most. Depending on the study that is either a limitation or an advantage: short exposure windows are exactly what you need to examine pulsatile rather than continuous receptor signalling. Analogues built to survive that cleavage exist for the opposite case — modified GRF 1-29, with its substituted position 2, and tesamorelin, with an acyl group on the N-terminus.

Research applications

Pituitary and hypothalamic physiology

Predominantly it is used as the reference GHRH receptor agonist in cell and animal studies: binding assays, cAMP readouts, somatotroph responsiveness, and characterisation of pulsatile secretion in intact animals. In these papers sermorelin is the yardstick rather than the subject.

Diagnostic endocrinology

In the United States, sermorelin acetate was formerly marketed on prescription for stimulation testing of growth hormone and for growth hormone deficiency in children. It was withdrawn from that market in 2008 on commercial grounds, not because of safety findings. Those clinical data describe a licensed medicine administered under medical supervision, not research-grade material.

Comparative structure–activity studies

Because stabilised GHRH analogues are judged against sermorelin, it appears throughout the literature on tesamorelin and modified GRF 1-29. Head-to-head discussions are in tesamorelin vs sermorelin and CJC-1295 versus sermorelin.

Combination pharmacology

Another line of work combines GHRH receptor agonists with ghrelin receptor agonists such as ipamorelin. The two receptors occupy the same cell but signal through different second messengers — cAMP on one side, phospholipase C on the other — and in some models the combination produces more than the two effects added together. Research material is sold pre-blended for this purpose.

Available formats and vial sizes

Freeze-dried sermorelin comes in sealed vials at three sizes: 2 mg for USD 45, 5 mg for USD 75 and 10 mg for USD 120. Its molecular weight of 3357.93 g/mol makes the 5 mg vial about 1.49 micromoles. For receptor pharmacology at nanomolar concentrations that goes a very long way; in animal studies it disappears far faster. You will find the GHRH peptides under GHRH analogs, part of the wider growth hormone and performance peptides grouping.

Reconstitution and storage at the bench

An example: reconstitute a 5 mg vial with 2 mL of bacteriostatic water and you have 2.5 mg/mL (2,500 mcg/mL), so 0.1 mL — the 10-unit graduation on a U-100 syringe — holds 250 mcg. In molar terms, 2.5 mg/mL of a peptide weighing 3357.93 g/mol is roughly 745 µM, so reaching 10 nM in a receptor assay means diluting about 75,000-fold — done as a series of steps, never in a single dilution.

Two stability points are peculiar to this peptide. Met27 oxidises readily, so protect stock solutions from air and light. And in any biological matrix containing active DPP-4, breakdown begins at once — that is a methodological constraint, not a storage one. Keep freeze-dried vials at −20 °C, dry and dark; aliquot reconstituted peptide and keep it cold. See the reconstitution guide and the storage guide for specifics.

Purity and reading the certificate of analysis

Every lot goes through reversed-phase purification to 99% or higher, has its mass verified, and ships with a lot-specific certificate. Three things are worth checking on it. Start with the amide: the measured mass ought to be 3357.93 g/mol, and about a dalton more than that means you have the free acid. Then look for oxidation of Met27 — a +16 Da satellite peak, or a shoulder coming off the column ahead of the main peak. Finally consider resolution. A 29-mer is a reasonably demanding synthesis, and a chain lacking a single residue can elute practically underneath the product, so a method that separates them well is worth as much as a high number on the page. Our COA reading guide applies these to genuine documents.

Regulatory position

Sermorelin acetate held US marketing authorisation until it was withdrawn in 2008, and in some countries compounding pharmacies prepare sermorelin against a prescription. Research-grade peptide is not a pharmaceutical, comes with none of the associated regulatory guarantees, and is sold for laboratory research only — never for human consumption.

Related compounds and further reading

Within the GHRH family, the stabilised short analogue is modified GRF 1-29, the long-acting albumin-binding version is CJC-1295 with DAC, and the acylated full-length analogue is tesamorelin. Ipamorelin, GHRP-2 and GHRP-6 belong on the other side of the axis, acting through a different receptor entirely. The whole picture is mapped out in the GH secretagogue landscape explained.

Matching catalogue section: GHRH Analogs